IL2 and neoplasm: Eliminating lymphocytes in the tumor microenvironment facilitates infused cells’ trafficking to the tumor site and their accessibility to various homeostatic cytokines, including IL-2, IL-7, and IL-15, while also reducing immunosuppressive cells that impair antigen-presentation.